CNY 19.03
(1.49%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 73.29 Million | 21.42 Million | 55.16 Million | 82.28 Million | 79.92 Million | 15.61 Million |
Net Income | 56.24 Million | -51.79 Million | 20.67 Million | 233.35 Million | 131.8 Million | 43.59 Million |
Depreciation & Amortization | 61.05 Million | 26.68 Million | 30.32 Million | 17.06 Million | 12.7 Million | 9.43 Million |
Deferred income taxes | 8.78 Million | -10.71 Million | 593 Thousand | -3.26 Million | -1.89 Million | -2.24 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -93.58 Million | 9.92 Million | -420.24 Thousand | -222.95 Million | -80.38 Million | -59.93 Million |
Other non-cash items | 256.5 Million | 36.6 Million | 4.58 Million | 54.82 Million | 15.79 Million | 22.51 Million |
Investing Cash Flow | -163.19 Million | -497.24 Million | -55.94 Million | -216.06 Million | -21.01 Million | -1.09 Million |
Investments in PPE | -167.19 Million | -431.09 Million | -163.01 Million | -85.64 Million | -13.06 Million | -4.34 Million |
Acquisitions | - | -34.19 Million | -2.09 Million | 85.64 Million | -2.77 Million | - |
Investment purchases | - | -106.9 Million | -20 Million | -231.53 Million | -66.76 Million | -2.61 Million |
Sales/Maturities of investments | 4 Million | 40.03 Million | 129.16 Million | 101.11 Million | 66.82 Million | 3.05 Million |
Other Investing Activities | 4 Million | 34.91 Million | 0.84 | -85.64 Million | -5.24 Million | 2.81 Million |
Financing Cash Flow | 271.09 Million | 89.71 Million | 514.03 Million | 31.13 Million | 21.77 Million | 31.24 Million |
Debt repayment | -300 Million | -90 Million | -236.65 Million | -395 Million | -372 Million | -75.98 Million |
Dividends payments | -27.1 Million | -16 Million | -21.56 Million | -15.17 Million | -12.24 Million | -6.71 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -27.1 Million | 201.42 Million | 757.55 Million | 441.31 Million | 406.02 Million | 113.94 Million |
Accounts receivables | -175.99 Million | 67.07 Million | 191.22 Million | -144.2 Million | -40.95 Million | -109.06 Million |
Accounts payables | 461.48 Million | 40.42 Million | -186.35 Million | -53.39 Million | 36.97 Million | 86.98 Million |
Inventory | -379.07 Million | -86.86 Million | -5.89 Million | -22.38 Million | -74.51 Million | -35.61 Million |
Other working capital | 470.26 Million | -10.71 Million | 593 Thousand | -2.97 Million | -1.89 Million | -24.32 Million |
Cash at beginning of period | 151.33 Million | 537.16 Million | 23.94 Million | 126.59 Million | 45.91 Million | 141.92 Thousand |
Cash at end of period | 337.2 Million | 151.07 Million | 537.16 Million | 23.94 Million | 126.59 Million | 45.91 Million |
Capital Expenditure | -167.19 Million | -431.09 Million | -163.01 Million | -85.64 Million | -13.06 Million | -4.34 Million |
Effect of forex changes on cash | - | 9497.44 | -40.57 Thousand | - | - | - |
Net cash flow / Change in cash | 185.87 Million | -386.09 Million | 513.21 Million | -102.64 Million | 80.68 Million | 45.77 Million |
Free Cash Flow | -93.9 Million | -409.67 Million | -107.84 Million | -3.35 Million | 66.85 Million | 11.26 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -18.55 Million | 44.48 Million | 21.42 Million | 43.94 Million | 56.24 Million | 55.1 Million |
Depreciation & Amortization | - | 26.1 Million | 26.1 Million | 20.16 Million | 61.05 Million | -20.66 Million |
Deferred income taxes | - | - | - | - | 8.78 Million | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -555.07 Million | -93.58 Million | 337.68 Million |
Other non-cash items | 138.56 Million | -183.64 Million | -301.82 Million | 162.76 Million | 256.5 Million | -231.79 Million |
Investing Cash Flow | -10.7 Million | -2.96 Million | -16.05 Million | -68.03 Million | -163.19 Million | -40.01 Million |
Investments in PPE | -10.79 Million | -2.96 Million | -16.35 Million | -69.5 Million | -167.19 Million | -42.54 Million |
Acquisitions | - | - | 300 Thousand | - | - | - |
Investment purchases | -300 Million | - | - | - | - | - |
Sales/Maturities of investments | 300.08 Million | - | - | 4 Million | 4 Million | - |
Other Investing Activities | - | - | 300 Thousand | -2.52 Million | 4 Million | 2.52 Million |
Financing Cash Flow | -188.86 Million | 222.67 Million | 92.44 Million | -13.47 Million | 271.09 Million | 1.81 Million |
Debt repayment | -107.54 Million | -227.45 Million | -100 Million | -10.5 Million | -300 Million | -15 Million |
Dividends payments | - | -565.27 Thousand | -2.21 Million | -24.44 Million | -27.1 Million | -919.99 Thousand |
Common Stock Repurchased | 10.69 Million | -10.69 Million | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -92.01 Million | 5.91 Million | -7.55 Million | -22.18 Million | -27.1 Million | 17.73 Million |
Accounts receivables | - | - | - | -175.99 Million | -175.99 Million | 188.46 Million |
Accounts payables | - | - | - | - | 461.48 Million | - |
Inventory | - | - | - | -379.07 Million | -379.07 Million | 149.22 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 187.66 Million | 133.13 Million | 337.2 Million | 231.32 Million | 151.33 Million | 125.11 Million |
Cash at end of period | 108.1 Million | 187.66 Million | 133.13 Million | 337.2 Million | 337.2 Million | 231.32 Million |
Capital Expenditure | -10.79 Million | -2.96 Million | -16.35 Million | -69.5 Million | -167.19 Million | -42.54 Million |
Effect of forex changes on cash | - | - | - | - | - | 4.08 Million |
Net cash flow / Change in cash | -79.56 Million | 54.52 Million | -204.06 Million | 105.88 Million | 185.87 Million | 106.21 Million |
Free Cash Flow | 109.21 Million | -168.21 Million | -296.74 Million | 117.03 Million | -93.9 Million | 97.78 Million |
603638
ISLCONSUL
PAT
PKTEA
028260
KA